Feb 01 2012
Roche displays his confidence for 2012
The Swiss pharmaceutical company Roche made Wednesday his confidence for the current fiscal year while announcing a 2011 annual result in line with expectations despite significant currency effects. Roche also pointed out that the year 2012 was marked by the takeover bid that leads on American society Illumina Genome Sequence . Revenues fell 10% to 42.53 billion Swiss francs (35.29 billion euros), while analysts had expected 42.37 billion. At constant exchange rates (CER), it appears, however, an increase of 1%. The Pharmaceuticals Division has contributed nearly $ 32.79 billion, down 12% year on year. Sales and the Diagnostics Division for their part, declined 7% to 9.74 billion but increased by 6% TCC. Markets expected 32.69 billion for the Pharmaceuticals Division and 9.73 billion for the Diagnostics Division. The net profit was up 7% in France and 26% TCC to 9.54 billion francs, while the market had forecast 9.49 billion. The Board of Directors propose a dividend of 6.80 francs per share and enjoy good (titles stripped of voting rights) for the past year against previous 6.60 francs ; ously. "As for 2012, we expect sales growth of the group in the lower part of the medium single-digit range and have set our target for growth in earnings per Share core activities in the upper part, "said CEO Severin Schwan said in a statement. Roche also aims for its Diagnostics division higher growth than the market and is committed to pursue its attractive dividend policy. The Director General also reiterated that all the hopes placed in Illumina Roche, the U.S. company for which his group has launched a tender offer unsolicited e at a cost of $ 5.7 billion. "The planned acquisition of Illumina will strengthen our presence in the fast growing market of DNA sequencing and enable the discovery of biomarkers for complex research and to clinical purposes, "he said.
Free printable business cards are very easy to create. You simply download the template you like to your computer, fill in your information, and print!Comments Off
